Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Biocryst Pharmaceuticals buy melinda

Biocryst Pharmaceuticals
Start price
€3.22
10.06.19 / 50%
Target price
€6.31
04.11.21
Performance (%)
208.00%
End price
€9.92
05.11.21
Summary
This prediction ended on 05.11.21 with a price of €9.92. The BUY prediction by melinda for Biocryst Pharmaceuticals saw massive gains of 208.00%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Biocryst Pharmaceuticals 19.437% 19.437% 17.172% 18.504%
iShares Core DAX® -4.932% -11.977% -3.485% 44.537%
iShares Nasdaq 100 -2.634% -2.218% 13.783% 80.994%
iShares Nikkei 225® -4.733% -10.900% 19.712% 45.258%
iShares S&P 500 -2.544% -3.540% 8.878% 61.123%

Comments by melinda for this prediction

In the thread Biocryst Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 208.00%
Target price 6.314
Change
Ends at 04.11.21

Biotechnologie und Medizintechnik SecteurRecherche Agenda 20/02 Ergebnisse Veröffentlichung



Beruf
Logo BioCryst Pharmaceuticals,
Entwirft und entwickelt kleinmolekulare Arzneimittel

BioCryst Pharmaceuticals, Inc. ist in der Forschung, Entwicklung und Vermarktung von Biopharmazeutika tätig.

Das Portfolio umfasst Rapivab, Inhibitoren von Kallikrein und Bcx4430.

Diese Medikamente haben die Absicht , Influenza und hereditären Angioödem zu behandeln.

Das Unternehmen wurde 1986 gegründet und befindet sich in Durham, North Carolina ansässig.

Anzahl der Mitarbeiter: 65 Personen.



melinda 
0
Report Share
10.06.19
In the thread Trading Biocryst Pharmaceuticals
Prediction Buy
Perf. (%) 208.00%
Target price 6.314
Change
Ends at 04.11.21

Die von melinda gewählte maximale Laufzeit wurde überschritten

melinda 
0
Report Share
05.11.21

Stopped prediction by melinda for Biocryst Pharmaceuticals

buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€4.03
05.02.18
€5.12
15.02.18
11.52%
15.02.18

melinda 
18.08.19 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€4.24
07.11.17
€4.96
02.01.18
18.30%
02.01.18

melinda 
14.08.19 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€4.70
07.11.17
€5.50
02.01.18
18.30%
02.01.18

melinda 
14.08.19 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€4.32
09.08.13
€5.00
10.02.14
55.25%
10.02.14

melinda 
14.08.19 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€4.04
04.09.10
€5.50
04.03.11
-25.77%
04.03.11

melinda 
14.08.19 50%